Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)”Rosa De Miguel,David Rial-Crestelo,Lourdes Dominguez-Dominguez,Rocío Montejano,Andrés Esteban-Cantos,Paula Aranguren-Rivas,Natalia Stella-Ascariz,Otilia Bisbal,Laura Bermejo-Plaza,Mónica Garcia-Alvarez,Belén Alejos,Asunción Hernando,Mireia Santacreu-Guerrero,Julen Cadiñanos,Mario Mayoral,Juan Miguel Castro,Victoria Moreno,Luz Martin-Carbonero,Rafael Delgado,Rafael Rubio,Federico Pulido,José Ramón ArribaseBioMedicine(2023)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要